Abstract
A neonate with elevated tetradecenoylcarnitine (C14:1) on the newborn screen was evaluated for possible very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) and found to be a carrier. However, his symptom-free mother was subsequently diagnosed with VLCADD. This documents maternal VLCADD causing a positive newborn screening result in an offspring.
Copyright © 2011 Mosby, Inc. All rights reserved.
MeSH terms
-
Acyl-CoA Dehydrogenase, Long-Chain / blood
-
Acyl-CoA Dehydrogenase, Long-Chain / deficiency
-
Carnitine / analogs & derivatives
-
Carnitine / blood
-
Congenital Bone Marrow Failure Syndromes
-
Female
-
Genotype
-
Humans
-
Infant, Newborn
-
Lipid Metabolism, Inborn Errors
-
Male
-
Metabolism, Inborn Errors / blood
-
Metabolism, Inborn Errors / diagnosis
-
Mitochondrial Diseases / blood
-
Mitochondrial Diseases / diagnosis
-
Mothers
-
Muscular Diseases / blood
-
Muscular Diseases / diagnosis
-
Neonatal Screening / methods*
-
Phenotype
Substances
-
acylcarnitine
-
Acyl-CoA Dehydrogenase, Long-Chain
-
Carnitine